PTK2 and neoplasm: Representative IVIS imaging at day 45 showed that cisplatin-treated FAK-WT tumor burden was greater than that of FAK-NLS− tumor-bearing mice (Fig. 5D) and was significantly greater at day 49 (Fig. 5E).